| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = -$309 ) |
| 2024 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 7 | 4/19/2024 | NON-COMPETING CONTINUATION | -$280 |
| 2024 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 001 | 7 | 4/19/2024 | SUPPLEMENT FOR EXPANSION | -$28 |
|
 | Issue Date FY: 2023 ( Subtotal = $841,079 ) |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 003 | 7 | 8/14/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 7 | 12/5/2022 | NON-COMPETING CONTINUATION | $687,719 |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 002 | 7 | 3/3/2023 | NON-COMPETING CONTINUATION | $76,413 |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 001 | 7 | 12/7/2022 | SUPPLEMENT FOR EXPANSION | $76,947 |
|
 | Issue Date FY: 2022 ( Subtotal = $841,079 ) |
| 2022 | 2022 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 002 | 6 | 6/29/2022 | NON-COMPETING CONTINUATION | $76,413 |
| 2022 | 2022 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 001 | 6 | 12/10/2021 | SUPPLEMENT FOR EXPANSION | $76,947 |
| 2022 | 2022 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 6 | 12/7/2021 | NON-COMPETING CONTINUATION | $687,719 |
|
 | Issue Date FY: 2021 ( Subtotal = $801,327 ) |
| 2021 | 2021 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 002 | 5 | 8/20/2021 | SUPPLEMENT FOR EXPANSION | $37,195 |
| 2021 | 2021 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 001 | 5 | 5/15/2021 | NON-COMPETING CONTINUATION | $76,414 |
| 2021 | 2021 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 5 | 12/17/2020 | NON-COMPETING CONTINUATION | $687,718 |
|
 | Issue Date FY: 2020 ( Subtotal = $764,132 ) |
| 2020 | 2020 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 001 | 4 | 3/13/2020 | NON-COMPETING CONTINUATION | $38,207 |
| 2020 | 2020 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 4 | 12/19/2019 | NON-COMPETING CONTINUATION | $725,925 |
|
 | Issue Date FY: 2019 ( Subtotal = $764,132 ) |
| 2019 | 2019 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cardiovascular Diseases Research | 000 | 3 | 12/21/2018 | NON-COMPETING CONTINUATION | $764,132 |
|
 | Issue Date FY: 2018 ( Subtotal = $764,132 ) |
| 2018 | 2018 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Lung Diseases Research | 000 | 2 | 12/14/2017 | NON-COMPETING CONTINUATION | $748,849 |
| 2018 | 2018 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Lung Diseases Research | 001 | 2 | 7/14/2018 | NON-COMPETING CONTINUATION | $15,283 |
|
 | Issue Date FY: 2017 ( Subtotal = $764,131 ) |
| 2017 | 2017 | VANDERBILT UNIVERSITY, THE | 211 KIRKLAND HALL | NASHVILLE | TN | 37240 | DAVIDSON | USA | Lung Diseases Research | 000 | 1 | 1/11/2017 | NEW | $764,131 |
|
|